正业科技与益方生物近期动态及市场表现概览

Group 1: Company Overview - The companies mentioned are "Zhengye Technology" (300410) and "Yifang Bio" (688382), both of which have names related to "bio" and sound similar to "Zhengye" [1] Group 2: Stock Performance - As of January 25, 2026, Yifang Bio's stock price increased by 5.29% during that week, although there was a net outflow of main funds [2] Group 3: Financial Performance - Yifang Bio's Q3 2025 report indicated that both revenue and net profit grew year-on-year for the first three quarters [3] - Despite the growth in revenue, the company reported a negative net profit for the first three quarters of 2025, as it remains in the research and development investment phase [5] Group 4: Recent Developments - Yifang Bio has initiated an "A+H" share listing plan, having submitted a listing application to the Hong Kong Stock Exchange on January 1, 2026 [4] - The company has received approval for two innovative drugs, which have been included in the national medical insurance catalog [5]